机构:[1]Department of Rheumatology and Immunology, Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital, No. 197 Ruijin Second Road, Huangpu District, Shanghai 200025, China[2]Department of Rheumatology and Immunology, Sichuan University West China Hospital, Chengdu, China四川大学华西医院[3]Department of Rheumatology and Immunology, Guangdong General Hospital, Guangzhou, China广东省人民医院[4]Department of Rheumatology and Immunology, The First Hospital Affiliated to China Medical University, Shenyang, China[5]Department of Rheumatology and Immunology, Zhejiang University School of Medicine First Affiliated Hospital, Hangzhou, China浙江大学医学院附属第一医院[6]Department of Rheumatology and Immunology, Sichuan People’s Hospital, Chengdu, China[7]Department of Rheumatology and Immunology, Second Xiangya Hospital, Changsha, China[8]Department of Rheumatology and Immunology, Xinjiang Uygur People’s Hospital, No. 91 Tianchi Road, Tianshan District, Urumqi 830001, Xinjiang Uygur Autonomous Region, China[9]Department of Rheumatology and Immunology, Jiangsu People’s Hospital, Nanjing, China江苏省人民医院[10]Department of Rheumatology and Immunology, Changhai Hospital, Shanghai, China[11]Beijing Institute of Traumatology and Orthopaedics, Beijing Jishuitan Hospital, Fourth Clinical Medical College, Peking University, Beijing, China
To estimate the mortality and describe the causes of death in a large multicenter cohort of hospitalized patients with SLE in China. This was a retrospective study of a nationwide SLE cohort (10 centers, 29,510 hospitalized patients) from 2005 to 2014 in China. Standardized mortality ratios (SMRs) were calculated for all death and were stratified by sex and age. Chi-square test was used to determine whether the major causes of death vary in age, sex, duration of SLE, disease activity, or medications. Comparison between dead patients and survival controls was used to identify the risk factors for mortality. Logistic regression analysis was used to evaluate the risk factors for mortality. A total of 360 patients died during the study period, accounting for 1.22%. The overall SMR was 2.13 (95% CI 1.96, 2.30), with a particularly high SMR seen in subgroups characterized by younger age. Infection (65.8%) was the most common cause of death, followed by lupus nephritis (48.6%), hematological abnormality (18.1%), neuropsychiatric lupus/NPSLE (15.8%), and interstitial pneumonia (13.1%). Cardiovascular disease and malignancy contributed little to the causes of death. Infection, in particular severe pulmonary infection, emerged as the foremost risk factor for mortality, followed by lupus encephalopathy. However, lupus nephritis and hematological abnormalities occurred more frequently in survival patients. SLE patients at a younger age of diagnosis have a poorer prognosis. Infection dominated the causes of death in recent China. Ethnicity and medications might account for the differences in causes of death compared with western populations.
基金:
National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81671589, 81502016]
第一作者机构:[1]Department of Rheumatology and Immunology, Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital, No. 197 Ruijin Second Road, Huangpu District, Shanghai 200025, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Wu Xin-yao,Yang Min,Xie Yue-sheng,et al.Causes of death in hospitalized patients with systemic lupus erythematosus: a 10-year multicenter nationwide Chinese cohort[J].Clinical rheumatology.2019,38(1):107-115.doi:10.1007/s10067-018-4259-z.
APA:
Wu, Xin-yao,Yang, Min,Xie, Yue-sheng,Xiao, Wei-guo,Lin, Jin...&Liu, Hong-lei.(2019).Causes of death in hospitalized patients with systemic lupus erythematosus: a 10-year multicenter nationwide Chinese cohort.Clinical rheumatology,38,(1)
MLA:
Wu, Xin-yao,et al."Causes of death in hospitalized patients with systemic lupus erythematosus: a 10-year multicenter nationwide Chinese cohort".Clinical rheumatology 38..1(2019):107-115